Kynam Capital Management’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.87M | Sell |
3,067,774
-201,373
| -6% | -$254K | 0.42% | 24 |
|
|
2025
Q1 | $2.99M | Buy |
3,269,147
+863,000
| +36% | +$788K | 0.25% | 28 |
|
|
2024
Q4 | $3.83M | Buy |
2,406,147
+50,000
| +2% | +$79.5K | 0.23% | 27 |
|
|
2024
Q3 | $4.62M | Buy |
2,356,147
+709,445
| +43% | +$1.39M | 0.35% | 22 |
|
|
2024
Q2 | $2.7M | Buy |
1,646,702
+578,175
| +54% | +$948K | 0.21% | 21 |
|
|
2024
Q1 | $5.49M | Hold |
1,068,527
| – | – | 0.57% | 19 |
|
|
2023
Q4 | $6.12M | Hold |
1,068,527
| – | – | 0.68% | 21 |
|
|
2023
Q3 | $5.11M | Buy |
+1,068,527
| New | +$5.11M | 0.84% | 20 |
|